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Abstract 
Background: An improved understanding of the vascular function, measured in non‑invasive way, in constantly 
growing group of patients at increased risk of cardiovascular events is necessary. To evaluate the effects of metabolic 
syndrome in morbidly obese patients and body mass reduction secondary to gastric bypass surgery on convenient 
and new non‑invasive markers of artery function: pulse wave velocity (PWV), flow‑ and nitroglycerin‑mediated dilata‑
tion (FMD, NTG).
Methods: There were 40 patients included into prospective study, who were qualified for bariatric surgery (OB1) and 
evaluated again 6 m after surgery (OB2). A control group (CG) consisted of 15 healthy women. A second control group 
(CG2) consisted of 15 women with grade 1 obesity. PWV, FMD, NTG were assessed.
Results: The reduction of BMI (kg/m2) from 47.73 ± 6.18 (OB1) to 35.22 ± 5.20 (OB2) was observed. The PWV turned 
out to be higher before bariatric surgery (OB1 vs. OB2 8.53 ± 1.76 vs. 7.82 ± 1.49 m/s; p < 0.001), however it was 
no different than PWV in CG. In OB1 group PWV showed correlation with age (r = 0.492, p = 0.001), HR (r = 0.324, 
p = 0.04), %FM (r = 0.328; p = 0.039), NTG% (r = −0.332, p = 0.036) as well as hsCRP (r = 0.394, p = 0.014). A 
multivariate analysis showed that the most significant factors influencing PWV were age (p = 0.0005) and hsCRP 
(p = 0.0014), pseudo R2 index 0.44365. The values of FMD differed between OB1 and OB2 groups (12.83 ± 5.15 vs. 
17.52 ± 5.50 %; p < 0.0001), however, they were similar to results obtained in CG (14.45 ± 6.14 %; NS). The values of 
nitroglycerin‑mediated dilatation differed between OB1 and OB2 groups (21.47 ± 8.31 vs. 28.54 ± 8.16 %; p < 0.0001) 
and were lower as compared with CG (31.42 ± 5.95 %; p = 0.0005).
Conclusion: Body mass reduction secondary to bariatric surgery in patients with severe obesity and metabolic 
syndrome results in improvement of functional markers of artery function and advantageous metabolic changes. 
The improvement in functional markers of artery function (NTG%) was correlated with change in triglyceride blood 
concentration.
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Background
According to World Health Organization obesity is an 
abnormal fat accumulation in the body that may impair 
health [1, 2]. The most commonly used obesity classifi-
cation depends on body mass index (BMI), where BMI 
≥40 kg/m2 indicates severe obesity.
The severe obesity and metabolic syndrome were, until 
recently, a medical problem concerning only rich coun-
tries, but the latest studies have shown that the problem 
is also present in developing countries in Asia and almost 
worldwide. An overweight results in a significant increase 
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in the risk of chronic-degenerative diseases and death [3]. 
One should underline that body mass increase results 
in elevated risk of one or more diseases from the above 
mentioned group [1]. A meta-analysis of 15 prospective 
studies, which included 258 114 patients, showed that an 
increase in waist circumference of 1 cm leads to the ele-
vation of the risk of cardiovascular disease of 2 %, while 
an increase of WHR by 0.01, results in cardiovascular 
disease risk being elevated by 5 % [4].
Bariatric surgery is currently an established treatment 
method; an part of complex and interdisciplinary thera-
peutic approach to patients with severe obesity and met-
abolic syndrome [5]. The indications for bariatric surgery 
in patients aged 18–65 years include BMI ≥40 kg/m2 or 
BMI 35–40  kg/m2 with co-morbidities, the severity of 
which is expected to decrease with body mass reduction 
[5].
Vascular remodeling assessment is non-invasive, 
repeatable, and relatively not expensive [6]. The results of 
measurements often correlate with the presence of car-
diovascular risk factors [7] and arteriosclerosis and allow 
to predict the risk of fatal and non-fatal cardiovascular 
events [6, 8]. They are recommended by guidelines to be 
the early markers of vascular damage, including: pulse 
wave velocity (PWV), flow-mediated dilatation (FMD), 
and nitroglycerin-mediated dilatation (NTG) [9–11].
Objectives
The objective of this study was to determine whether 
severe obesity in women with metabolic syndrome leads 
to functional remodeling of arterial wall and change 
in the corresponding markers. At the same time we 
assessed the effect of body mass reduction on the above 
mentioned markers following bariatric surgery.
Methods
To the prospective study, we recruited 40 premenopau-
sal, morbidly obese women undergoing qualification 
for bariatric surgery. They were re-assessed 6  months 
after the bariatric procedure. The inclusion criteria 
were as follows: severe obesity (BMI >40  kg/m2), meta-
bolic syndrome, age >18 and <60 years, female sex. The 
exclusion criteria were: type 2 diabetes mellitus, history 
of myocardial infarction, clinically significant valvu-
lar heart disease, chronic kidney disease, chronic liver 
disease, chronic obstructive pulmonary disease, smok-
ing (>20 cigarettes/day), polytherapy, obstructive sleep 
apnea. The control group consisted of 15 people of mid-
dle age, 36  ±  8.34  years, and average body weight of 
60.72 ± 5.12 kg. The patients in the control group were 
matched for sex and age. In all patients included in the 
study, physical examination and medical interview as well 
as basic laboratory tests, electrocardiography and PWV, 
FMD, NTG assessments were performed.
The evaluation of brachial artery vasodilation was 
performed in accordance with “Guidelines for the ultra-
sound assessment of endothelial-dependent flow-medi-
ated vasodilation of the brachial artery: a report of the 
International Brachial Artery Reactivity Task Force” [12]. 
Thus, in every patient all measurements of FMD and 
NTG were performed under fasting conditions, after at 
least 12  h without smoking and withholding treatment 
with any vasodilators. The examination was performed 
twice (before and 6 months after surgery), in accordance 
with a protocol in supine position. The brachial artery 
was subjected to imaging in the 2D longitudinal plane, 
using Philips iE 33 system device (Andeouver, Massachu-
setts, USA) with a 5–7 MHz linear transducer.
Pulse wave velocity was measured in all patients in 
accordance with the established protocol. The PWV eval-
uation was performed after night rest according to the 
European Society of Cardiology guidelines, using Com-
plior SR device (Artech Medical, Paris, France), equipped 
with two TY-306 tonometric sensors detecting blood 
pressure variability in the range of 0.01–100  Hz, which 
includes harmonic frequencies of pressure wave gener-
ated by variable heartbeat rate. When the impulses were 
detected, registered and processed by a computer, the 
signal was enhanced, in order to obtain pulse wave curve 
from carotid and femoral artery. Next, a transit time 
delay between the two pressure waves was automatically 
calculated, as well as mathematic estimation of the veloc-
ity of pulse wave propagation (according to equation: dis-
tance between the points of measurements on the body 
surface/transit time delay) was performed. The study pro-
tocol was approved by the Local Bioethics Committee.
Statistical analysis
The quantitative variables were presented using standard 
descriptive statistics: means, standard deviation for nor-
mally distributed variables, medians and ranges for not-
normally distributed variables. For quantitative variables 
a hypothesis of their normal distribution was tested using 
a Shapiro–Wilk test and a graphical Q–Q plot. When the 
analyzed variable was distributed normally, a hypoth-
esis of an equal difference in means in both data sets was 
tested using a t test. While comparing two groups show-
ing not normal distribution of analyzed characteristic, 
a Wilcoxon test for two independent samples was used. 
In the analysis of quantitative parameters assessed dur-
ing the treatment, the respective tests for paired samples 
were used: the t-test for normally distributed variables 
and the Wilcoxon test for variables showing distribution 
other than normal. In correlation analysis of quantitative 
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variables, a Pearson correlation coefficient was used for 
normally distributed variables, while variables showing 
other kind of distribution were analyzed using a Spear-
man correlation coefficient. The association between 
categorical variables was tested in the set of contingency 
tables, using a Chi squared test or a Fisher’s exact test, if 
expected values in table cells were not high enough (i.e. 
above 5). In the analysis of categorical parameters dur-
ing the treatment, a McNemar’s test of symmetry for 
two related samples was used. In the analysis of the influ-
ence of selected factors on analyzed parameters (PWV, 
FMD%, NTG%), the multidimensional, generalized lin-
ear models (GLMs) were used. In GLMs the optimal type 
of link function and error distribution were assigned. 
The optimal model was selected using stepwise variable 
selection strategy. As the first model selection criterion, 
a minimal value of Akaike’s Information Criterion was 
used. The selected model, being the best fit for the data, 
was described using the Pearson Chi Squared and pseudo 
R-Squared statistics. The assumed level of statistical sig-
nificance was p  <  0.05. All calculations were performed 
using SAS9.2 System.
Results
General clinical characteristics of patients with severe 
obesity and control group
There were 40 premenopausal female patients with severe 
obesity in the middle age, 36.4 ± 9.0 years; recruited into 
the study and 15 female patients recruited into the con-
trol group (36 ± 8.3 years vs. 36.4 ± 9.0 years; NS). Every 
bariatric surgery was performed by the same team of sur-
geons. All patients with severe obesity were reassessed at 
6  months after surgery in order to undergo post-opera-
tive evaluation.
Anthropometric data of patients were summarized in 
Table 1.
There were 40 (100  %) patients with hypertension in 
the study population (n = 40). During the course of the 
study, 30 (75  %) patients received 2 or more antihyper-
tensive drugs (including angiotensin converting enzyme 
inhibitors and diuretics); and 10 (25  %) patients used 
only one antihypertensive agent (angiotensin convert-
ing enzyme inhibitor). In 11 (27.5  %) patients, predia-
betes was diagnosed, including 6 (15  %) patients with 
impaired fasting glucose (IFG) and 7 (17.5  %) patients 
with impaired glucose tolerance (IGT) [13]. In 2 (5  %) 
patients both of the above mentioned abnormalities were 
observed simultaneously. The patients with diagnosed 
type 2 diabetes mellitus were excluded from the study. 
Disorders of lipid metabolism were present in 22 (55 %) 
patients and obstructive sleep apnea of at most moderate 
severity was diagnosed in 8 (20 %) patients.
Evaluation of basic biochemical parameters in patients 
with severe obesity and in the control group
Basic biochemical parameters of patients with severe 
obesity and metabolic syndrome s well as in the control 
group were summarized in Table 2.
Evaluation of functional vascular markers in patients 
with severe obesity and in the control group
The results of comparative analysis of markers of artery 
function in patients qualified for bariatric surgery and in 
the control group were summarized in Table 3.
In severely obese patients the tendency to nitro-
glycerin-mediated vasodilation (21.47  ±  8.31  % vs. 
31.42 ± 5.95; p < 0.05) was lower. There were no differ-
ences between study populations in mean values of pulse 
wave velocity and flow-mediated dilatation.
Table 1 Anthropometric data of patients qualified for bar-
iatric surgery and of the control group
Values are presented mean ± SD
BMI body mass index, EBW excess body weight
OB1 (n = 40) Control group (n = 15) p
Body weight (kg) 132.03 ± 18.42 60.73 ± 5.12 <0.0001
BMI (kg/m2) 47.73 ± 6.18 21.61 ± 1.41 <0.0001
Fat (%) 49.15 ± 3.83 25.13 ± 4.88 <0.0001
Fat mass (kg) 65.25 ± 12.81 45.37 ± 3.7 <0.0001
BW (kg) 72.34 ± 16.75
Table 2 Evaluation of  basic biochemical parameters 
in  patients with  severe obesity and  metabolic syndrome 
and in the control group
a Median; range
b Mean ± SD
OB1 (n = 40) CG (n = 15) p
Fasting glucose (mg/dl)a 89; 67–124 90; 81–102 NS
Fasting insulin (µIU/ml)a 14.07; 5.45–56.33 6.81; 3.57–12.73 <0.0001
HOMAa 3.31; 1.14–11.68 1.61; 0.78–3.02 <0.0001
Glucose level 2 h after 
OGTT (mg/dl)a
109.58 ± 31.16 95.27 ± 24.14 NS
Insulin level 2 h after OGTT 
(µIU/ml)a
46.53; 6.23–273.1 19.22; 7.21–52.56 0.001
HbA1C (%)
a 5.65; 5.20–10.90 5.60; 5.30–5.80 0.001
Creatinine (mg/dl)b 0.76 ± 0.16 0.77 ± 0.08 NS
Total cholesterol (mg/dl)b 199.15 ± 35.13 184.07 ± 28.68 NS
HDL‑chol (mg/dl)b 52.55 ± 10.97 69.53 ± 10.36 0.001
LDL‑chol (mg/dl)b 120.30 ± 31.59 102.07 ± 25.32 0.04
Triglycerides (mg/dl)b 124.78 ± 47.70 63.80 ± 41.02 0.001
hsCRP (mg/l)b 10.19 ± 6.92 0.93 ± 0.76 NS
GFR (ml/min)b 96.14 ± 20.76 91.97 ± 16.19 NS
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Changes in values of anthropometric parameters 
in patients with severe obesity
A comparison of basic anthropometric and biochemical 
parameters in patients before and 6 months after bariat-
ric surgery was presented in Table 4.
It is worth noticing that in the above comparison 
hyperinsulinemia was observed in 19 (47.5 %) patients in 
OB1 group and in 6 (15  %) patients in OB2 group. The 
index HOMA values of insulin resistance showed statis-
tically significant differences between the groups (1.76; 
0.35–24.80 vs. 3.31; 1.16–11.68; p < 0.0001). The insulin 
resistance was diagnosed in 26 (67  %) patients in OB1 
group and in 9 (22.5  %) patients in OB2 group. In 18 
patients 6 months after the surgery, the parameters diag-
nostic for insulin resistance got normal. HbA1C results 
showed statistically significant differences between the 
groups (5.35; 4.70–6.10 vs. 5.65; 5.20–6.60; p  <  0.0001). 
There were also statistically significant differences found 
in the total cholesterol, triglycerides and hsCRP concen-
trations. There were no differences in creatinine, HDL 
cholesterol and LDL cholesterol concentrations, as well 
as in GFR results.
Evaluation of markers of artery function in patients 
with severe obesity before and after surgery (OB1 vs. OB2)
A comparison of markers of artery function in patients in 
OB1 and OB2 groups was presented in Table 5.
There were statistically significant differences observed 
in the values of all investigated parameters (PWV, FMD, 
NTG).
Correlations
In the group of patients with normal body weight, a nega-
tive correlation between body fat mass and pulse wave 
velocity (r  =  −0.49, p  =  0.063) of borderline statisti-
cal significance was observed. Additionally there were 
the following correlations observed: between PWV and: 
age (r = 0.49; p = 0.06), FM (kg) (r = −0.49; p = 0.06), 
heart rate (r  =  −0.59, p  =  0.02); GFR (r  =  −0.6; 
p = 0.0171), creatinine (r = 0.54; p = 0.0372) and HDL 
cholesterol (r =  0.55; p =  0.0331). In OB1 group a cor-
relation between pulse wave velocity and age (r =  0.49; 
p = 0.0012) or pulse rate (r = 0.324; p = 0.041) was also 
observed, likewise in control group. A positive correlation 
Table 3 Comparison of  markers of  artery function 
in  patients qualified for  bariatric surgery and  in the con-
trol group






 Mean ± SD 8.53 ± 1.76b 7.98 ± 1.24b NS
 Median; range 8.45; 5.30–14.40a 7.77; 5.30–10.55a
FMD (%)
 Mean ± SD 12.83 ± 5.15b 14.45 ± 6.14b NS
 Median; range 12.29; 1.80–21.84a 15.77; 3.89–23.80a
NTG (%)
 Mean ± SD 21.47 ± 8.31b 31.42 ± 5.95b 0.0005
 Median; range 21.72; 3.52–40.78a 32.48; 20.22–42.69a
Table 4 Comparison of  basic anthropometric and  bio-
chemical parameters in  patients before  (OB1) 
and 6 months after (OB2) bariatric surgery
OB1 (n = 40) OB2 (n = 40) p
Body weight (kg) 132.03 ± 18.42 97.46 ± 15.35 <0.0001
BMI (kg/m2) 47.73 ± 6.18 35.22 ± 5.20 <0.0001
FAT (%) 49.15 ± 3.83 38.20 ± 5.66 <0.0001
FFM (kg) 66.78 ± 7.84 59.90 ± 8.92 <0.0001
EBW (kg) 72.34 ± 16.75 37.77 ± 13.97 <0.0001
Fasting glucose (mg/dl) 90.40 ± 10.19 85.35 ± 9.50 0.0139
Fasting insulin (µIU/ml) 17.68 ± 11.29 13.26 ± 20.99 <0.0001
HOMA 3.89 ± 2.33 2.79 ± 4.53 <0.0001
Glucose level 2 h after OGTT 
(mg/dl)
109.58 ± 31.16 80.20 ± 20.18 <0.0001
Insulin level 2 h after OGTT 
(µIU/ml)
60.72 ± 53.92 13.77 ± 10.64 <0.0001
HbA1C (%) 5.80 ± 0.89 5.37 ± 0.30 <0.0001
Creatinine (mg/dl) 0.76 ± 0.16 0.77 ± 0.12 NS
Total cholesterol (mg/dl) 199.15 ± 35.13 189.75 ± 29.64 <0.0001
HDL‑chol (mg/dl) 52.55 ± 10.97 54.50 ± 9.68 NS
LDL‑chol (mg/dl) 120.30 ± 31.59 113.25 ± 28.42 NS
Triglycerides (mg/dl) 124.78 ± 47.70 94.58 ± 40.82 <0.0001
hsCRP (mg/l) 10.19 ± 6.92 4.76 ± 5.62 <0.0001
GFR (ml/min) 96.14 ± 20.76 93.69 ± 19.30 NS
Table 5 A comparison of  markers of  artery function 
in patients before and 6 months after bariatric surgery





PWV (m/s) 8.53 ± 1.76b 7.82 ± 1.49b 0.0226
8.45; 5.30–14.40a 7.63; 4.58–10.99a
FMD (%) 12.83 ± 5.15b 17.52 ± 5.50b <0.0001
12.29; 1.80–21.84a 17.22; 6.30–27.41a
NTG (%) 21.47 ± 8.31b 28.54 ± 8.16b <0.0001
21.72; 3.52–40.78a 26.92; 13.86–48.63a
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with % of fatty tissue %FM (r  =  0.328; p  =  0.039) and 
marker of inflammation hsCRP (r  =  0.393, p  =  0.014), 
as well as a negative correlation with nitroglycerin-medi-
ated vasodilation results (r  =  −0.332; p  =  0.036) are 
worth noticing.
Changes in investigated parameters 6 months 
after bariatric surgery
An examination performed 6  months after bariatric 
surgery revealed decrease in EBW of 34.57  ±  9.71  kg. 
A change in NTG values (ΔNTG%) was correlated 
with change in triglycerides concentration (r  =  0.343, 
p = 0.04).
Following analysis of the influence of particular vari-
ables on PWV value, the following variables were con-
sidered as the most significant among the investigated 
parameters: age (p  =  0.0005) and hsCRP (p  =  0.0014). 
The value of a deviance (Pearson Chi Squared) was 0.10 
and the value of pseudo-R2 was 0.44365.
Following analysis of the influence of particular vari-
ables on FMD% it turned out, that the best model fit 
involved substantial random component (bad fit), which 
meant that among investigated variables, there were no 
statistically significant factors influencing the value of 
analyzed parameter. The best model fit involved the fol-
lowing variables: age (NS) and hsCRP (NS). The value 
of a deviance (Pearson Chi Squared) was 889.26 and the 
value of pseudo-R2 was 0.02352.
Discussion
In this paper a non-invasive evaluation of the artery func-
tion extend in patients with severe obesity, compared to 
control group with normal body weight, was performed, 
as well as assessment of efficiency of surgical treatment for 
obesity in normalization of the above mentioned param-
eters. The study population involved 40 female patients in 
middle age 36.4 ± 9.0 with severe obesity, meeting quali-
fication criteria for bariatric surgery [5]. Patients qualified 
for bariatric surgery showed no significant age differences 
in comparison with controls. Comparing the two groups, 
higher fasting insulin levels and index HOMA values of 
insulin resistance were found in patients qualified for bar-
iatric surgery. The fasting insulin level exceeding 15 µIU/
ml and indicating hyperinsulinemia was observed in 19 
(48.71  %) patients with severe obesity and additionally 
67 % of patients with severe obesity were diagnosed with 
insulin resistance. Neither hyperinsulinemia, nor insulin 
resistance was observed in patients in control group.
In both groups there were no differences in mean val-
ues of PWV and FMD%, however, in the group of severely 
obese patients lower values of NTG% were observed.
Following 6  months of follow-up period after surgery 
a significant decrease in BMI from 47.73 ±  6.18  kg/m2 
to 35.22 ±  5.20  kg/m2 (p  <  0.0001) and in excess body 
weight (EBW) from 72.34 ± 16.75 kg to 37.77 ± 13.97 kg 
(p  <  0.0001) was observed. A detailed analysis revealed 
that after 6  months of follow-up the problem of severe 
obesity was applicable to only 7 out of 40 patients (18 %), 
while 6 (15 %) patients were classified to category of BMI 
<30 kg/m2 indicating only overweight.
An increased pulse wale velocity is and established risk 
factor of cardiovascular complications and it is believed 
to be one of the signs of adverse artery function in 
patients with hypertension. In the obese patients, both 
before and after surgery, the PWV values were higher 
than 12  m/s, which is the upper limit of normal. How-
ever, it should be noticed that PWV values in the group of 
obese patients before bariatric surgery were significantly 
higher than 6  months after procedure in OB2 group 
(8.53 ± 1.76 m/s vs. 7.82 ± 1.49 m/s; p = 0.0226). In mul-
tidimensional analysis as the most significant variables 
for predicting PWV values, the following parameters 
were chosen: age (p = 0.0005) and hsCRP (p = 0.0014), 
the value of pseudo-R2 was 0.44365. The above result is in 
accordance with the findings of Pirro et al., who showed 
that CRP concentration is, apart from standard risk fac-
tors of cardiovascular diseases, independent predictor 
of increased vessel stiffness and with the results of the 
study by Flegall et  al., where decrease in vessels elastic-
ity progressing with age and independent from BMI was 
observed.
To the best of our knowledge in the available literature 
there are no studies including study populations, which 
could serve as a reference for our investigated popula-
tion. Nordstrand et  al. in their study in women with 
severe obesity found on the basis of measurements per-
formed by Sphygmocor device that the mean values of 
PWV accounted for 8.1 m/s [14].
Flow- and nitroglycerin-mediated vasodilation values 
in OB1 and OB2 group showed statistically significant 
differences (12.83 ± 5.15 vs. 17.52 ± 5.50 %; p < 0.0001; 
and 21.47  ±  8.31 vs. 28.54  ±  8.16  %; p  <  0.0001) and 
were lower than in CG. Kearney et  al. in their study in 
8 patients, who underwent bariatric surgery, found 
that mean body mass reduction of 23.4  kg resulted in 
improvement of FMD from 5.3 to 10.2 %. In the available 
literature there are no studies, which could be a refer-
ence for our study population. Arkan et al. in their study 
in 203 obese patients found that body weight is a signifi-
cant predictor of vessels dysfunction. The FMD values 
correlated with body weight (β = −0.23, p = 0.005) but 
not with BMI [15]. Benjamin et  al. investigated group 
of patients taking part in Framingham Heart Study and 
found negative correlation between BMI and FMD [16].
Biasucci et  al. described paradoxically good vessels 
function in patients with severe obesity. Comparing 
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small groups of patients with severe obesity or obesity 
with people having normal weight, they found higher 
values of FMD in severely obese patients group 
than in groups of obese or normal weight patients 
(13.02  ±  6.50  % vs. 7.53  ±  5.47  %, p  =  0.019 and 
13.02  ±  6.50  % vs. 7.33  ±  3.68  %, p  =  0.011, respec-
tively). The authors did not reveal any difference in 
FMD between group of normal weight participants 
and group of severely obese patients (7.33 ± 3.68 % vs. 
7.53 ± 5.47 %, NS) [17].
Arkan et al. in their study in 203 obese patients found 
that body weight is an important predictor of vessels dys-
function. The FMD values correlated with body weight 
(β  =  −0.23, p  =  0.005) but not with BMI [15]. Benja-
min et  al. investigated group of patients taking part in 
Framingham Heart Study and found negative correlation 
between BMI and FMD [16].
Study limitations
While discussing study results, its limitations should be 
considered. During observation in the study, patients 
continued their medications. In the investigated popu-
lation antihypertensive drugs were used: enalapril, loop 
diuretics, calcium channel blockers; the control group 
denied any drug use. Considering potentially high cardio-
vascular risk in the investigated population, authors did 
not decide to stop medications before performing study 
measurements. It is worth noticing that the above men-
tioned dugs were used also before the first measurements 
were taken.
Conclusions
In summary one should notice that non-invasive evalu-
ation of functional markers of artery function and met-
abolic indicators implies their negative changes in the 
group of women with severe obesity as compared with 
healthy controls. In obese patients following only short 
(6  months) postoperative period, the improvement of 
functional markers of artery function and advantageous 
metabolic changes were observed. The improvement in 
functional markers of artery function (NTG%) was corre-
lated with change in triglycerides blood concentration. It 
is worth noticing that in the group of patients with severe 
obesity and metabolic syndrome, the variables influenc-
ing pulse wave velocity were age and hsCRP concentra-
tion. Further observation of investigated population is 
recommended.
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